A detailed history of D. E. Shaw & Co., Inc. transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 1,023,264 shares of IART stock, worth $22.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,023,264
Holding current value
$22.7 Million
% of portfolio
0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$17.14 - $31.74 $2.88 Million - $5.33 Million
167,912 Added 19.63%
1,023,264 $18.6 Million
Q2 2024

Aug 14, 2024

BUY
$23.14 - $34.72 $7.76 Million - $11.7 Million
335,557 Added 64.56%
855,352 $24.9 Million
Q1 2024

May 15, 2024

BUY
$33.4 - $45.2 $3.61 Million - $4.88 Million
107,938 Added 26.21%
519,795 $18.4 Million
Q4 2023

Feb 14, 2024

SELL
$34.21 - $44.59 $1.22 Million - $1.59 Million
-35,733 Reduced 7.98%
411,857 $17.9 Million
Q3 2023

Nov 14, 2023

BUY
$37.8 - $45.97 $1.66 Million - $2.02 Million
43,922 Added 10.88%
447,590 $17.1 Million
Q2 2023

Aug 14, 2023

BUY
$37.95 - $58.98 $2.07 Million - $3.22 Million
54,618 Added 15.65%
403,668 $16.6 Million
Q1 2023

May 15, 2023

SELL
$52.61 - $60.49 $775,629 - $891,804
-14,743 Reduced 4.05%
349,050 $20 Million
Q4 2022

Feb 14, 2023

BUY
$42.17 - $58.6 $2.38 Million - $3.31 Million
56,439 Added 18.36%
363,793 $20.4 Million
Q3 2022

Nov 14, 2022

BUY
$42.28 - $57.17 $128,869 - $174,254
3,048 Added 1.0%
307,354 $13 Million
Q2 2022

Aug 15, 2022

BUY
$53.86 - $66.52 $2.31 Million - $2.85 Million
42,826 Added 16.38%
304,306 $16.4 Million
Q1 2022

May 16, 2022

BUY
$62.86 - $69.24 $14.3 Million - $15.8 Million
227,936 Added 679.51%
261,480 $16.8 Million
Q4 2021

Feb 14, 2022

SELL
$62.47 - $73.25 $780,875 - $915,625
-12,500 Reduced 27.15%
33,544 $2.25 Million
Q3 2021

Nov 15, 2021

SELL
$64.97 - $76.19 $2.87 Million - $3.37 Million
-44,190 Reduced 48.97%
46,044 $3.15 Million
Q2 2021

Aug 16, 2021

SELL
$66.79 - $76.63 $3.15 Million - $3.61 Million
-47,145 Reduced 34.32%
90,234 $6.16 Million
Q1 2021

May 17, 2021

SELL
$62.63 - $71.15 $4.12 Million - $4.68 Million
-65,764 Reduced 32.37%
137,379 $9.49 Million
Q4 2020

Feb 16, 2021

SELL
$43.31 - $66.55 $5.6 Million - $8.6 Million
-129,294 Reduced 38.89%
203,143 $13.2 Million
Q3 2020

Nov 16, 2020

SELL
$43.33 - $51.72 $2.27 Million - $2.71 Million
-52,430 Reduced 13.62%
332,437 $15.7 Million
Q2 2020

Aug 14, 2020

SELL
$41.42 - $55.57 $4.57 Million - $6.13 Million
-110,264 Reduced 22.27%
384,867 $18.1 Million
Q1 2020

May 15, 2020

BUY
$36.67 - $61.04 $3.39 Million - $5.65 Million
92,553 Added 22.99%
495,131 $22.1 Million
Q4 2019

Feb 14, 2020

SELL
$55.73 - $62.49 $1.18 Million - $1.32 Million
-21,114 Reduced 4.98%
402,578 $23.5 Million
Q3 2019

Nov 14, 2019

SELL
$53.29 - $64.59 $367,701 - $445,671
-6,900 Reduced 1.6%
423,692 $25.5 Million
Q2 2019

Aug 14, 2019

SELL
$46.45 - $55.85 $2.45 Million - $2.94 Million
-52,694 Reduced 10.9%
430,592 $24 Million
Q1 2019

May 15, 2019

BUY
$42.97 - $57.33 $2.03 Million - $2.71 Million
47,297 Added 10.85%
483,286 $26.9 Million
Q4 2018

Feb 14, 2019

SELL
$42.62 - $64.51 $726,244 - $1.1 Million
-17,040 Reduced 3.76%
435,989 $19.7 Million
Q3 2018

Nov 14, 2018

SELL
$57.63 - $65.87 $3.44 Million - $3.93 Million
-59,730 Reduced 11.65%
453,029 $29.8 Million
Q2 2018

Aug 14, 2018

BUY
$54.05 - $67.23 $20.2 Million - $25.1 Million
373,809 Added 269.02%
512,759 $33 Million
Q1 2018

May 15, 2018

BUY
$46.55 - $57.38 $181,498 - $223,724
3,899 Added 2.89%
138,950 $7.69 Million
Q4 2017

Feb 14, 2018

SELL
$46.22 - $51.77 $373,503 - $418,353
-8,081 Reduced 5.65%
135,051 $6.46 Million
Q3 2017

Nov 14, 2017

BUY
$47.8 - $53.63 $6.84 Million - $7.68 Million
143,132
143,132 $7.23 Million

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.85B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.